The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study
Authors:
- 18 August 2010
- journal article
- retinal disorders
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 249 (2) , 179-182
Abstract
Purpose To examine the association between age-related macular degeneration (AMD) and the risk of myocardial infarctions (MIs) in a large health maintenance organization. Design A retrospective cohort study carried out at Maccabi Healthcare Services (MHS). Participants A total of 6,546 patients aged ≥65 years who were diagnosed with AMD between April 18 1996 and June 6 2008, and 61,672 non-AMD patients frequency-matched for age and gender. Methods Participants were retrospectively followed to the day of leaving the MHS, to undergoing an MI, or to closure of the study on July 1 2008, whichever came earlier. The relative risk of MI associated with AMD was estimated using the Cox proportional hazard model. Main Outcome Measures Incident myocardial infarction events. Results During the study period, there were 159 (5.1 per 1,000 person years [PY]) and 2,997 (4.2 per 1,000 PY) MIs respecively in the AMD and non-AMD patient groups. The age- and gender-adjusted hazard ratio (HR) of MI among AMD patients was 1.01 (95%CI: 0.85–1.20). Baseline medical characteristics associated with increased risk of mortality included diabetes mellitus, hypertension, older age, and male gender. The fully adjusted HR associated with AMD was 1.03 (95%CI: 0.87–1.22). Conclusion Despite the shared risk factors associated with AMD and MIs, we found no increased risk of MI in AMD patients.Keywords
This publication has 27 references indexed in Scilit:
- Age-related macular degeneration and mortality from cardiovascular disease or strokeBritish Journal of Ophthalmology, 2008
- Age-Related Macular Degeneration and Risk of Coronary Heart DiseaseOphthalmology, 2007
- The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBritish Journal of Ophthalmology, 2006
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- The association of cardiovascular disease with the long-term incidence of age-related maculopathyOphthalmology, 2003
- Genetic Association of Apolipoprotein E with Age-Related Macular DegenerationThe American Journal of Human Genetics, 1998
- Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular DegenerationScience, 1997
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group1994